Other articles of interest

Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness

Marc Llagostera-Martín, Miguel Cainzos, Neus Salvatella, Héctor Cubero-Gallego, Aleksandra Mas-Stachurska, Andrea Sánchez-Carpintero, Helena Tizón-Marcos, Alicia Calvo-Fernández, Luis Molina, Beatriz Vaquerizo,

Rev Esp Cardiol. 2024;77:150-7
Bleeding and embolic risk in patients with atrial fibrillation and cancer

Sergio Raposeiras-Roubín, Emad Abu-Assi, Tamara Fernández Sanz, Cristina Barreiro Pardal, Isabel Muñoz Pousa, Maria Melendo Viu, Pablo Domínguez Erquicia, Ana Ledo Piñeiro, Andrea Lizancos Castro, Inmaculada González Bermúdez, Xavier Rosselló, Borja Ibáñez, Andrés Íñiguez Romo,

Rev Esp Cardiol. 2023;76:344-52
Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

Sergio Raposeiras-Roubín, Emad Abu-Assi, María Cespón Fernández, Sonia Blanco Prieto, Cristina Barreiro Pardal, Pablo Domínguez-Erquicia, María Melendo Viu, Clara Bonanad Lozano, Xavier Rosselló, Borja Ibáñez, Andrés Íñiguez Romo,

Rev Esp Cardiol. 2022;75:334-42